Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Frontiers in Pharmacology|January 11, 2020
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and ValidationLucy Meunier, Dominique LarreyAnnals of Hepatology|February 17, 2020
Chemotherapy-associated steatohepatitisLucy Meunier, Dominique LarreyAnnals of Hepatology|February 23, 2018
Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory DrugsLucy Meunier, Dominique LarreyInternational Journal of Molecular Sciences|January 8, 2023
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype SusceptibilityLucy Meunier, Dominique LarreyAnnals of Hepatology|June 15, 2017
Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?Dominique Larrey, Lucy Meunier, José Ursic-BedoyaClinics and Research in Hepatology and Gastroenterology|March 6, 2021
Hydrochlorothiazide-induced hepatotoxicity: A rare case of DILIEmilie Malézieux, Lucy Meunier, Benjamin Rivière, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2018
Pantoprazole-induced autoimmune chronic hepatitisLucy Meunier, Jose Ursic-Bedoya, Georges-Philippe Pageaux, et al.Frontiers in Pharmacology|February 7, 2022
Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver InjuryBénédicte Delire, Eleonora De Martin, Lucy Meunier, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2024
Drug-induced liver injury related to gene therapy: A new challenge to be managedDominique Larrey, Benedicte Delire, Lucy Meunier, et al.JHEP Reports : Innovation in Hepatology|July 4, 2024
CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatmentLucy Meunier, Eleonora De Martin, Bénédicte Delire, et al.Pageof 17